http://id.loc.gov/vocabulary/iso639-2/eng
Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
Heidelberg
2017
Heidelberg 2017
XII, 108 Seiten
http://id.loc.gov/vocabulary/iso639-2/eng
Development of a CD22-specific chimeric antigen receptor (CAR) for the adoptive T cell therapy of leukemia and lymphoma
Heidelberg
2020
Heidelberg 2020
1 Online-Ressource (XII, 108 Seiten)
http://dx.doi.org/10.11588/heidok.00022968
urn:nbn:de:bsz:16-heidok-229686